Patient: MICHENER, PAMELA JOAN Age: 42 y

PHN: 9807601579 Gender: Female

Date of Birth: 10/May/1980 VPP MRN:BC9807601579
Ordering Provider:CLARK, VIRGINIA
CopyTo(s):
Admission Date: 05/Apr/2023
Discharge Date: 06/Apr/2023
Lab #: BGY23-585178
Collected: 24/Mar/2023 00:00
Received: 04/Apr/2023 00:00
Time Resulted

Pathology
Cervical Cancer Screening 30/Jun/2023 10:45
BC Cancer
686 West Broadway
Vancouver, BC V5Z 4E6
Tel Number: 1-877-PHSA-LAB
Fax Number: 604-707-2809

CERVICAL CANCER SCREENING REPORT

Accession # BGY23-585178
SOURCE OF SPECIMEN(S)
A: Cervix/ Endocervix
-Spatula and/or Brush, PreservCyt LBC vial
===========================================================================
INTERPRETATION
A: Cervix/ Endocervix
Specimen satisfactory for evaluation. Endocervical / transformation zone
component present.
ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE.
RECOMMENDATION
Please repeat cervical cancer screening in 6 months.

DIAGNOSIS COMMENT
Investigation for the suspicious lesion as noted on the requisition is
advisable.

***Electronically Signed Out***

Dr. Deepu Alex, MD PhD
This is a screening procedure with the potential for false negative and
false positive results. If your patient has any clinically suspicious
lesions, abnormal bleeding or other relevant symptoms, further evaluation
is required, even if the screening test was normal.
===========================================================================

DATE OF LAST MENSTRUAL PERIOD: MAR 17 2023

REASON FOR SCREEN: Clinical Abnormality-Abnormal bleeding
Clinical Abnormality-Suspicious lesion
CLINICAL HISTORY: FRIABLE LESION 12 O'CLOCK CERVIX

Results performed at PHSA Laboratories unless otherwise indicated

For inquiries call 1-877-PHSA LAB (1-877-747-2522) or fax 604-708-8027
This printed PLIS report contains confidential personal information and is for direct care purposes only.
FINAL
Printed by: Health Gateway Printed On: 01/Jul/2023 08:28
RCV: 4.0 End of Report Page 1